Balance Sheet
Cash Flow Statement
AcquisitionsCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cimpress (CMPR) Asset Writedowns and Impairment (2016 - 2024)

Historic Asset Writedowns and Impairment for Cimpress (CMPR) over the last 9 years, with Q2 2024 value amounting to -$786000.0.

  • Cimpress' Asset Writedowns and Impairment fell 12167.08% to -$786000.0 in Q2 2024 from the same period last year, while for Jun 2024 it was $656000.0, marking a year-over-year decrease of 9021.92%. This contributed to the annual value of $5.6 million for FY2023, which is N/A changed from last year.
  • Cimpress' Asset Writedowns and Impairment amounted to -$786000.0 in Q2 2024, which was down 12167.08% from $328000.0 recorded in Q1 2024.
  • In the past 5 years, Cimpress' Asset Writedowns and Impairment registered a high of $20.6 million during Q1 2021, and its lowest value of -$3.2 million during Q2 2022.
  • In the last 5 years, Cimpress' Asset Writedowns and Impairment had a median value of $549000.0 in 2023 and averaged $2.1 million.
  • The largest annual percentage gain for Cimpress' Asset Writedowns and Impairment in the last 5 years was 34307.69% (2022), contrasted with its biggest fall of 37433.63% (2022).
  • Cimpress' Asset Writedowns and Impairment (Quarter) stood at $3.8 million in 2020, then fell by 27.67% to $2.7 million in 2021, then crashed by 134.1% to -$925000.0 in 2022, then surged by 163.68% to $589000.0 in 2023, then tumbled by 233.45% to -$786000.0 in 2024.
  • Its Asset Writedowns and Impairment stands at -$786000.0 for Q2 2024, versus $328000.0 for Q1 2024 and $589000.0 for Q4 2023.